The fill line, operational this summer, will offer a range of configurations including prefilled syringes, cartridges, and vials with ready-to-use components to minimize component preparation and packaging. The fill suite also houses two formulation suites, one of which is capable of handling flammable (class H) compounds.
Ajinomoto's Optima line uses Skan isolated barrier technology to guarantee the required sterility for fill finish and offers flexibility to meet current good manufacturing practices for clinical and commercial drugs, while in commercial compliance with the U.S. Food and Drug Administration. The high-speed process can move 22,000 syringes per hour through the line, with a batch capacity of over 200,000 syringes.
Copyright © 2021 scienceboard.net